Showing results (161-170 of 167) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Light, Science & Applications|December 6, 2023
Versatile optical manipulation of trions, dark excitons and biexcitons through contrasting exciton-photon couplingZhe Li, Xin-Yuan Zhang, Rundong Ma, et al.Oncotarget|November 19, 2016
Prognostic and diagnostic potential of isocitrate dehydrogenase 1 in esophageal squamous cell carcinomaXuan Chen, Qingbao Li, Cong Wang, et al.Scientific Reports|May 10, 2016
Notch2 as a promising prognostic biomarker for oesophageal squamous cell carcinomaCong Wang, Qingbao Li, Fang Liu, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 27, 2015
MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinomaShanghui Guan, Cong Wang, Xuan Chen, et al.Journal for Immunotherapy of Cancer|February 22, 2024
First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1%: results from a multicenter, open-label, phase 2 trialShengxiang Ren, Xicheng Wang, Bao-Hui Han, et al.Cancer Immunology, Immunotherapy : CII|May 10, 2024
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket studyShengxiang Ren, Anwen Xiong, Jia Yu, et al.The Lancet. Oncology|January 17, 2022
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trialQing Zhou, Ming Chen, Ou Jiang, et al.Pageof 17